These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 37993428

  • 1. PDPN+ CAFs facilitate the motility of OSCC cells by inhibiting ferroptosis via transferring exosomal lncRNA FTX.
    Li Y, Ma Z, Li W, Xu X, Shen P, Zhang SE, Cheng B, Xia J.
    Cell Death Dis; 2023 Nov 22; 14(11):759. PubMed ID: 37993428
    [Abstract] [Full Text] [Related]

  • 2. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L, Guo J, Fan Z, Yang S, Zhang C, Cheng B, Xia J.
    Cell Signal; 2023 Jun 22; 106():110635. PubMed ID: 36813147
    [Abstract] [Full Text] [Related]

  • 3. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
    Li YY, Tao YW, Gao S, Li P, Zheng JM, Zhang SE, Liang J, Zhang Y.
    EBioMedicine; 2018 Oct 22; 36():209-220. PubMed ID: 30243489
    [Abstract] [Full Text] [Related]

  • 4. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway.
    Yang W, Zhang S, Li T, Zhou Z, Pan J.
    Acta Biochim Biophys Sin (Shanghai); 2022 Sep 25; 55(2):262-273. PubMed ID: 36148955
    [Abstract] [Full Text] [Related]

  • 5. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
    Zhang X, Dong Y, Zhao M, Ding L, Yang X, Jing Y, Song Y, Chen S, Hu Q, Ni Y.
    Theranostics; 2020 Sep 25; 10(26):12044-12059. PubMed ID: 33204328
    [Abstract] [Full Text] [Related]

  • 6. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
    Zhang JY, Zhu WW, Wang MY, Zhai RD, Wang Q, Shen WL, Liu LK.
    J Transl Med; 2021 Dec 20; 19(1):513. PubMed ID: 34930321
    [Abstract] [Full Text] [Related]

  • 7. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
    Ding L, Ren J, Zhang D, Li Y, Huang X, Hu Q, Wang H, Song Y, Ni Y, Hou Y.
    Carcinogenesis; 2018 Mar 08; 39(3):397-406. PubMed ID: 29346528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
    Sun LP, Xu K, Cui J, Yuan DY, Zou B, Li J, Liu JL, Li KY, Meng Z, Zhang B.
    Oncol Rep; 2019 Oct 08; 42(4):1319-1328. PubMed ID: 31364748
    [Abstract] [Full Text] [Related]

  • 14. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
    Suzuki J, Aokage K, Neri S, Sakai T, Hashimoto H, Su Y, Yamazaki S, Nakamura H, Tane K, Miyoshi T, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Tsuboi M, Ishii G.
    Lung Cancer; 2021 Mar 08; 153():1-10. PubMed ID: 33429158
    [Abstract] [Full Text] [Related]

  • 15. Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma.
    Arebro J, Lee CM, Bennewith KL, Garnis C.
    Int J Mol Sci; 2024 Jan 21; 25(2):. PubMed ID: 38279300
    [Abstract] [Full Text] [Related]

  • 16. Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis.
    Yao F, Zhao Y, Wang G, Zhao M, Hong X, Ye Z, Dong F, Li W, Deng Q.
    Cell Signal; 2024 Aug 21; 120():111221. PubMed ID: 38729321
    [Abstract] [Full Text] [Related]

  • 17. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
    Li YY, Zhou CX, Gao Y.
    Exp Cell Res; 2018 Aug 01; 369(1):43-53. PubMed ID: 29719198
    [Abstract] [Full Text] [Related]

  • 18. Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.
    Lee HY, Yu NY, Lee SH, Tsai HJ, Wu CC, Cheng JC, Chen DP, Wang YR, Tseng CP.
    Biomed J; 2020 Apr 01; 43(2):146-162. PubMed ID: 32441651
    [Abstract] [Full Text] [Related]

  • 19. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
    Hwang BO, Park SY, Cho ES, Zhang X, Lee SK, Ahn HJ, Chun KS, Chung WY, Song NY.
    Front Immunol; 2021 Apr 01; 12():807600. PubMed ID: 34987523
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.